These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interactions of high salt intake and the response of the cardiovascular system to aldosterone. Conlin PR Cardiol Rev; 2005; 13(3):118-24. PubMed ID: 15831143 [TBL] [Abstract][Full Text] [Related]
3. Mineralocorticoid receptor activation in obesity hypertension. Nagase M; Fujita T Hypertens Res; 2009 Aug; 32(8):649-57. PubMed ID: 19521418 [TBL] [Abstract][Full Text] [Related]
4. Aldosterone antagonists: effective add-on therapy for the treatment of resistant hypertension. Gaddam KK; Pratt-Ubunama MN; Calhoun DA Expert Rev Cardiovasc Ther; 2006 May; 4(3):353-9. PubMed ID: 16716096 [TBL] [Abstract][Full Text] [Related]
5. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure. Dieterich HA; Wendt C; Saborowski F Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159 [TBL] [Abstract][Full Text] [Related]
6. [Involvement of Aldosterone and mineralocorticoid receptor in pathogenesis of cardiovascular diseases]. Miyamori I Nihon Rinsho; 2004 Mar; 62 Suppl 3():144-6. PubMed ID: 15171358 [No Abstract] [Full Text] [Related]
7. Expanding view of aldosterone action, with an emphasis on rapid action. Vinson GP; Coghlan JP Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):410-6. PubMed ID: 20409082 [TBL] [Abstract][Full Text] [Related]
8. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Bansal S; Lindenfeld J; Schrier RW Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361 [TBL] [Abstract][Full Text] [Related]
9. Normokalemic hyperaldosteronism in patients with resistant hypertension. Benchetrit S; Bernheim J; Podjarny E Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302 [TBL] [Abstract][Full Text] [Related]
10. Vascular actions of aldosterone. Briet M; Schiffrin EL J Vasc Res; 2013; 50(2):89-99. PubMed ID: 23172373 [TBL] [Abstract][Full Text] [Related]
11. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Bauersachs J; Fraccarollo D Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071 [TBL] [Abstract][Full Text] [Related]
12. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio. Hood SJ; Taylor KP; Ashby MJ; Brown MJ Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839 [TBL] [Abstract][Full Text] [Related]